NCT00195585View on ClinicalTrials.gov

Study Evaluating Isovorin in Colon Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Colon Cancer
Interventions
DRUG

Isovorin

DRUG

UFT

Trial Locations (1)

104-0031

Tokyo

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00195585 - Study Evaluating Isovorin in Colon Cancer | Biotech Hunter | Biotech Hunter